Diet, Gut Microbiota, and Histidine Metabolism Toward Imidazole Propionate Production in Relation to Type 2 Diabetes
- PMID: 40343485
- PMCID: PMC12178620
- DOI: 10.2337/dc24-2816
Diet, Gut Microbiota, and Histidine Metabolism Toward Imidazole Propionate Production in Relation to Type 2 Diabetes
Abstract
Objective: To examine associations of serum imidazole propionate (ImP), histidine, and their ratio with incident type 2 diabetes (T2D) and related dietary and gut microbial factors in U.S. Hispanic/Latino people.
Research design and methods: In the Hispanic Community Health Study/Study of Latinos, we evaluated serum ImP, histidine, and ImP-to-histidine ratio at baseline (2008-2011) and their cross-sectional associations with dietary intake and prospective associations with incident T2D over ∼12 years (n = 4,632). In a subsample with gut microbiota data during a follow-up visit (2016-2018), we examined gut microbial species associated with serum ImP and their potential interactions with dietary intake.
Results: Serum ImP and ImP-to-histidine ratio were positively associated with incident T2D (hazard ratio [95% CI] 1.17 [1.00-1.36] and 1.33 [1.14-1.55], respectively, comparing highest and lowest tertiles), whereas histidine was inversely associated with incident T2D (hazard ratio 0.75 [95% CI 0.64-0.86]). A higher amount of fiber intake was associated with lower serum ImP level and ImP-to-histidine ratio, whereas histidine intake was not associated with serum ImP level in the overall sample. Fifty-three bacterial species, including 19 putative ImP producers, were associated with serum ImP. Histidine intake was positively associated with serum ImP and ImP-to-histidine ratio only in participants with a high ImP-associated gut microbiota score (P = 0.03 and 0.02, respectively, for interaction). The associations of fiber intake with serum ImP and ImP-to-histidine ratio were partly mediated by ImP-associated gut microbiota (proportion mediated = 31.4% and 19.8%, respectively).
Conclusions: This study suggested an unfavorable relationship between histidine metabolism toward ImP production, potentially regulated by dietary intake and gut microbiota, and risk of T2D in U.S. Hispanic/Latino people.
© 2025 by the American Diabetes Association.
Conflict of interest statement
Similar articles
-
Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.Circulation. 2024 Jul 16;150(3):215-229. doi: 10.1161/CIRCULATIONAHA.124.069824. Epub 2024 Jun 19. Circulation. 2024. PMID: 39008559 Free PMC article.
-
Lutein augments the hypoglycemic effect of metformin through the gut microbiota-imidazole propionate axis in type 2 diabetic model mice.Sci Rep. 2025 Aug 27;15(1):31641. doi: 10.1038/s41598-025-16133-y. Sci Rep. 2025. PMID: 40866466 Free PMC article.
-
Association of the gut microbiota with type 2 diabetes: Links to disease and remission in the Japanese population.J Diabetes Investig. 2025 Jul;16(7):1315-1324. doi: 10.1111/jdi.70061. Epub 2025 May 7. J Diabetes Investig. 2025. PMID: 40331921 Free PMC article.
-
Effectiveness of Prebiotics and Mediterranean and Plant-Based Diet on Gut Microbiota and Glycemic Control in Patients with Prediabetes or Type 2 Diabetes: A Systematic Review and Meta-Analysis.Nutrients. 2024 Sep 27;16(19):3272. doi: 10.3390/nu16193272. Nutrients. 2024. PMID: 39408238 Free PMC article.
-
Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies.Nutrients. 2016 Nov 19;8(11):739. doi: 10.3390/nu8110739. Nutrients. 2016. PMID: 27869762 Free PMC article.
References
-
- Koh A, Molinaro A, Ståhlman M, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 2018;175:947–961.e17 - PubMed
MeSH terms
Substances
Grants and funding
- R01HL140976/HL/NHLBI NIH HHS/United States
- R01 DK120870/DK/NIDDK NIH HHS/United States
- N01 HC065236/HL/NHLBI NIH HHS/United States
- R01DK119268/DK/NIDDK NIH HHS/United States
- R01 HL141824/HL/NHLBI NIH HHS/United States
- R01 HL148094/HL/NHLBI NIH HHS/United States
- N01 HC065237/HL/NHLBI NIH HHS/United States
- R01 DK126698/DK/NIDDK NIH HHS/United States
- N01 HC065233/HL/NHLBI NIH HHS/United States
- R01 MD011389/MD/NIMHD NIH HHS/United States
- N01 HC065235/HL/NHLBI NIH HHS/United States
- R01 DK119268/DK/NIDDK NIH HHS/United States
- P30 DK111022/DK/NIDDK NIH HHS/United States
- N01 HC065234/HL/NHLBI NIH HHS/United States
- K01 HL150406/HL/NHLBI NIH HHS/United States
- P30 ES023515/ES/NIEHS NIH HHS/United States
- R01 DK134672/DK/NIDDK NIH HHS/United States
- R01 AG085320/AG/NIA NIH HHS/United States
- R01 HL140976/HL/NHLBI NIH HHS/United States
- R01HL140976/HL/NHLBI NIH HHS/United States
- R01DK119268/DK/NIDDK NIH HHS/United States
- R01HL148094/HL/NHLBI NIH HHS/United States
- R01DK126698/DK/NIDDK NIH HHS/United States
- R01 DK137968/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical